DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ. et al.
IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC).
Journal of Clinical Oncology 2018;
36: 578 , ASCO GU Abstract 578
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.